/PRNewswire/ "The second quarter of the year saw an improvement in EBIT compared with recent quarters, continued high gross margins, strong growth and an.
/PRNewswire/ Devyser s novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening.
/PRNewswire/ Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA PALB2. These kits offer efficient, targeted,.
/PRNewswire/ Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted regulatory approval in Canada. Devyser already.
/PRNewswire/ "The first quarter of the year saw continued strong growth, record gross margin and the launching of our first IVDR-approved product. After the.